Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Payout of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DP until

34.858 (0.466%)
NAV on January 20, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,287 cr
Turnover Ratio 28.44%
Expense Ratio 0.68%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: -1.88%
  • 1Y: 30.93%
  • 3M: -2.56%
  • 3Y: 22.41%
  • 6M: 11.87%
  • 5Y: 27.81%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since almost 4 years) Rajat Srivastava (Since 4 months)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 36.83
P/B Ratio 5.54
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 3.93
Beta 0.92
R-Squared 96.84
Info Ratio 1.21
Tracking Err 3.00
Sortino 2.095
Sharpe 1.029
Std Dev 15.208
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.17%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.83%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet
-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund